CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- 4 Shares withheld for taxes SVP Controller gave up 3,286 shares (to pay taxes)
- 4 Open-market sale Director sold 1,021 shares at $779.00 ($795,359)
- 4 Open-market sale EVP Finance CFO sold 1,491 shares at an average $776.80 ($1,158,204)
- 4 Open-market sale Director sold 100 shares at an average $756.13 ($75,613)
- 4 Open-market sale EVP Commercial sold 1,100 shares at $752.19 ($827,409)
- 4 Open-market sale Director sold 1 shares at $747.00 ($747)
- 4 Open-market sale Director sold 3,070 shares at $747.14 ($2,293,720)
- 4 Open-market sale Director sold 100 shares at an average $726.29 ($72,629)
- 4 Open-market sale EVP Commercial sold 1,100 shares at $721.86 ($794,046)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 165 shares (grant or award)
- 4 Grant or award Director acquired 40 shares (grant or award)
- 4 Open-market sale Director sold 5,758 shares at an average $714.11 ($4,111,822)
Page 13 of 77 · 1,533 filings